Gene profiling assay and application: the predictive role in primary therapy.

Area of Science:

• Oncology
• Genomics
• Biomarkers

Background:

• Breast cancer treatment options like endocrine therapy, chemotherapy, and targeted therapy improve survival.
• Current clinical tests lack predictive value for cancer treatment response.
• Individual markers have demonstrated limited predictive capability.

Purpose of the Study:

• To identify predictive gene expression signatures for breast cancer treatment response.
• To evaluate the utility of gene expression profiling in the neoadjuvant setting.

Main Methods:

• Utilizing gene expression profiling studies.
• Analyzing tumor biopsies from the neoadjuvant setting for multiple time points.
• Assessing direct response to treatment.

Main Results:

• Gene expression profiling studies have been conducted to find predictive signatures.
• The neoadjuvant setting is suitable for assessing treatment response and obtaining tumor samples.
• Current signatures lack sufficient discriminatory power for clinical use.

Conclusions:

• Gene expression profiling shows potential for predicting breast cancer treatment response.
• Further development is needed, including more effective therapies, standardized response definitions, and robust clinical trials.
• Microarrays require further validation before clinical decision-making implementation.